Market Research Report
Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2019 to 2024
|Published by||Howe Sound Research||Product code||854114|
|Published||Content info||177 Pages
Delivery time: 1-2 business days
|Cell Based Assay & High Content Screening Markets. Market Forecasts by Application. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2019 to 2024|
|Published: May 2, 2019||Content info: 177 Pages||
“Immuno-oncology frontier creating enormous market demand....”
Cell Based Assays are a mainstay of drug development and scientific research, but growth is now accelerating as new immuno-oncology markets create unprecedented investment in the race to cure cancer. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes: